NCT Number: NCT03284918
Lipid Lowering Effect of a Cereal Based Snack Bar With Added Plant Stanol Ester
The purpose of the study is to investigate the cholesterol lowering efficacy of a cereal based snack bar with added plant stanol ester when used between meals as part of a habitual diet by subjects with mild to moderate hypercholesterolemia.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–70 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Serum total cholesterol 5.2-8.5 mmol/l
- Serum triglycerides < 3 mmol/l
- Signed written informed consent
Exclusion criteria
- Abnormal liver, kidney and thyroid function
- Use of lipid lowering medication
- Consumption of other plant sterol or plant stanol containing food products or supplements, or other foods or supplements for cholesterol lowering 1 month prior to visit 2
- History of unstable coronary artery disease (myocardial infarction, coronary artery bypass graft (CABG), percutaneous transluminal coronary angioplasty (PTCA) within the previous 6 months
- Diagnosed type 1 or type 2 diabetes requiring medical treatment
- History of recent temporal ischemic attack or malignant diseases (< 5 yrs)
- Celiac disease, or allergy or intolerance to the ingredients of the test products
- Medically prescribed diet/medication for slimming or a special diet like very low calorie diet or obesity drug, or vegan and gluten-free diet
- Subjects with alcohol abuse (> 4 portion per day)
- Pregnancy or planned pregnancy or lactating
Treatment and study plan
Placebo
Dietary SupplementPrimary outcomes
-
Percentage change in serum LDL cholesterol
Time frame: 4 weeks
Secondary outcomes
-
Absolute change in serum LDL cholesterol (mmol/l)
Time frame: 4 weeks
-
Absolute and percentage change in serum total, HDL- and non-HDL cholesterol and serum total triglycerides
Time frame: 4 weeks
Sponsors and collaborators
Lead sponsor
Raisio Group
Industry
Collaborators
- Oy Medfiles Ltd
Registry information
Official study title
Effect of a Cereal Based Snack Bar With Added Plant Stanol Ester on Serum Total and Lipoprotein Lipids
Important dates
- Study start
- 2016
- Primary completion
- 2016
- Study completion
- 2016
- First posted
- Sep 15, 2017
- Registry last updated
- Sep 15, 2017
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Effects of Acute, Rapid Lowering of LDL Cholesterol With Alirocumab in Patients With STEMI Undergoing Primary PCI
NCT03718286
Acute Coronary Syndrome, Cardiovascular Diseases
Hamilton, Ontario, Canada
View Trial DetailsA Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia
NCT01435382
Dyslipidemias, Hypercholesterolemia
Chula Vista, California, United States
View Trial DetailsMeasure Liver Fat Content After ISIS 301012 (Mipomersen) Administration
NCT00362180
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Amsterdam, Netherlands
View Trial DetailsOpen Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia
NCT00477594
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Chicago, Illinois, United States
View Trial Details